CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 10, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020May

Monthly Archives: May, 2020

KEYTRUDA® plus LENVIMA® Combination Demonstrated Meaningful Tumor Response Rates in Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma

admin - 0
May 28, 2020: "Merck is known as MSD outside the United States and Canada, and Eisai announced new data from analyses of two trials...

Merck’s KEYTRUDA® Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer

admin - 0
May 28, 2020: "Merck known as MSD outside the United States and Canada, today announced the first presentation of results from KEYNOTE-177, a Phase...

Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020

admin - 0
May 28, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA...

FDA OK’s First Treatment for Bladder Dysfunction in children less than 2 years

admin - 0
May 26, 2020: "The U.S. FDA granted approval to VESIcare LS (solifenacin succinate) oral suspension, a liquid taken by mouth, for the treatment of...

Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020

admin - 0
May 27, 2020: The U.S. Food and Drug Administration continued to take action in the ongoing response effort to the COVID-19 pandemic: The FDA issued...

NICE u-turn backs Roche’s Tecentriq for small-cell lung cancer

admin - 0
May 28, 2020: "A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by the National Institute for Health and...

Roche’s OCREVUS shorter 2-hour infusion time approved

admin - 0
May 28, 2020: "Roche announced European Medicines Agency (EMA) approval of a new, shorter two-hour OCREVUS® (ocrelizumab) infusion time, dosed twice yearly, for relapsing...

Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir

admin - 0
May 28, 2020: "Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of...

Novartis data highlight benefit benefits of early treatment initiation in patients with secondary progressive multiple sclerosis (SPMS)

admin - 0
May 28, 2020: "Novartis announced today that Mayzent data from the Phase III EXPAND trial were published in the European Journal of Neurology after the 6th EAN,...

FDA OK’s for Johnson & Johnson’s SIRTURO® Pediatric formulation

admin - 0
May 27, 2020: "The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has granted approval for a new pediatric formulation...

AbbVie Presents New Data at the European E-Congress of Rheumatology 2020

admin - 0
May 27, 2020: "AbbVie announced that it will present new safety and efficacy results for RINVOQ™ (upadacitinib) in adult patients with moderate to severe...

What is the difference between the Central lab and local lab in clinical research?

admin - 4
Before understanding the difference between central lab and local lab, let's understand about "why lab tests are conducted" In Clinical trials, several lab tests need...
123...13Page 2 of 13
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved